|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.20 PLN | +0.17% |
|
+1.52% | -11.75% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10Cr | - | - | |||
| 455.46Cr | |||||
| 339.13Cr | - | ||||
| 202.64Cr | - | - | - | - | - |
| 192.44Cr | - | ||||
| 150.79Cr | - | - |
- Stock Market
- Stocks
- SCP Stock
- Charts Scope Fluidics S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
